1 | DVBCWSD3 ;ALB/CMM SKIN DISEASES (Other Than Scars) WKS TEXT - 1 ; 11/20/02 4:43pm
|
---|
2 | ;;2.7;AMIE;**49**;Apr 10, 1995
|
---|
3 | ;
|
---|
4 | ;
|
---|
5 | TXT ;
|
---|
6 | ;;A. Review of Medical Records:
|
---|
7 | ;;
|
---|
8 | ;;
|
---|
9 | ;;
|
---|
10 | ;;B. Medical History (Subjective Complaints):
|
---|
11 | ;;
|
---|
12 | ;; 1. Describe onset and course of disease, whether it is
|
---|
13 | ;; intermittent or constant, and whether it is progressive.
|
---|
14 | ;;
|
---|
15 | ;;
|
---|
16 | ;; 2. Describe current treatment. Specify the medication(s)
|
---|
17 | ;; used and dosage. State whether any is a corticosteroid
|
---|
18 | ;; or other immunosuppresive drug. State whether medications
|
---|
19 | ;; used are systemic or topical. Describe whether intensive
|
---|
20 | ;; light therapy, UVB, PUVA, or electron beam therapy are used.
|
---|
21 | ;;
|
---|
22 | ;;
|
---|
23 | ;; 3. For EACH treatment, report the frequency of use and duration
|
---|
24 | ;; of treatment during the past 12-month period.
|
---|
25 | ;;
|
---|
26 | ;;
|
---|
27 | ;; 4. Describe any side effects of treatment.
|
---|
28 | ;;
|
---|
29 | ;;
|
---|
30 | ;; 5. Describe local (skin) symptoms and any systemic symptoms,
|
---|
31 | ;; such as fever or weight loss.
|
---|
32 | ;;
|
---|
33 | ;;
|
---|
34 | ;; 6. For malignant neoplasms of skin, additionally describe
|
---|
35 | ;; all treatment, including date and type of last treatment.
|
---|
36 | ;;
|
---|
37 | ;;
|
---|
38 | ;; 7. For benign neoplasms of skin, additionally describe any
|
---|
39 | ;; impairment of function.
|
---|
40 | ;;
|
---|
41 | ;;
|
---|
42 | ;; 8. For urticaria, primary cutaneous vasculitis, and
|
---|
43 | ;; erythema multiforme, additionally describe the number of
|
---|
44 | ;; episodes during the past 12-month period, whether the
|
---|
45 | ;; episodes are debilitating, how they are treated, and
|
---|
46 | ;; whether they respond to treatment.
|
---|
47 | ;;
|
---|
48 | ;;C. Physical Examination (Objective Findings):
|
---|
49 | ;;
|
---|
50 | ;; 1. Report extent of disease - specify if any exposed areas
|
---|
51 | ;; (head, face, neck, and hands) are affected and the PERCENT
|
---|
52 | ;; OF EXPOSED AREAS that is affected and specify the PERCENT
|
---|
53 | ;; OF THE ENTIRE BODY that is affected.
|
---|
54 | ;;
|
---|
55 | ;;
|
---|
56 | ;; 2. If there is scarring or disfigurement, follow the "Scars"
|
---|
57 | ;; worksheet in addition to this one.
|
---|
58 | ;;
|
---|
59 | ;;
|
---|
60 | ;; 3. For acne or chloracne, describe whether the acne is
|
---|
61 | ;; superficial (with comedones, papules, pustules, superficial
|
---|
62 | ;; cysts) or deep (with deep inflamed nodules and pus-filled
|
---|
63 | ;; cysts), which areas of the body are affected, and,
|
---|
64 | ;; specifically, the PERCENT OF FACE AND NECK affected.
|
---|
65 | ;;
|
---|
66 | ;;
|
---|
67 | ;; 4. For scarring alopecia, describe the PERCENT OF THE SCALP
|
---|
68 | ;; that is affected.
|
---|
69 | ;;
|
---|
70 | ;;
|
---|
71 | ;; 5. For alopecia areata, describe whether there is loss of all
|
---|
72 | ;; body hair or whether loss of hair is limited to the scalp
|
---|
73 | ;; and face.
|
---|
74 | ;;
|
---|
75 | ;;
|
---|
76 | ;; 6. For hyperhidrosis, state whether veteran is able to handle
|
---|
77 | ;; paper or tools after therapy, or is unable to handle paper
|
---|
78 | ;; or tools because of moisture and is unresponsive to therapy.
|
---|
79 | ;;
|
---|
80 | ;;D. Diagnostic and Clinical Tests:
|
---|
81 | ;;
|
---|
82 | ;; 1. Biopsy, scrapings if indicated.
|
---|
83 | ;; 2. Include results of all diagnostic and clinical tests conducted
|
---|
84 | ;; in the examination report.
|
---|
85 | ;; 3. With disfigurement or disfiguring scar of head, face, or
|
---|
86 | ;; neck, submit COLOR PHOTOGRAPHS.
|
---|
87 | ;; 4. Test for hypoproteinemia if examining for exfoliative
|
---|
88 | ;; dermatitis (erythroderma).
|
---|
89 | ;;
|
---|
90 | ;;E. Diagnosis:
|
---|
91 | ;;
|
---|
92 | ;;
|
---|
93 | ;;Signature: Date:
|
---|
94 | ;;END
|
---|